8/12/2021
Good news was reported yesterday in the New England Journal of Medicine regarding the safety and efficacy data of Moderna’s COVID 19 vaccine in adolescents. With over 3,732 patients 12 to 17 years of age there were no serious adverse events and no cases of COVID-19 reported 2 weeks after the second dose.